These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 39353173)
1. Unveiling the Dynamic Mechanism of SARS-CoV-2 Entry Host Cells at the Single-Particle Level. Li S; Yang H; Tian F; Li W; Wang H; Shi X; Cui Z; Shan Y ACS Nano; 2024 Oct; 18(41):27891-27904. PubMed ID: 39353173 [TBL] [Abstract][Full Text] [Related]
5. V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity. Ou J; Zhou Z; Dai R; Zhang J; Zhao S; Wu X; Lan W; Ren Y; Cui L; Lan Q; Lu L; Seto D; Chodosh J; Wu J; Zhang G; Zhang Q J Virol; 2021 Jul; 95(16):e0061721. PubMed ID: 34105996 [TBL] [Abstract][Full Text] [Related]
6. Nonmuscle myosin heavy chain IIA facilitates SARS-CoV-2 infection in human pulmonary cells. Chen J; Fan J; Chen Z; Zhang M; Peng H; Liu J; Ding L; Liu M; Zhao C; Zhao P; Zhang S; Zhang X; Xu J Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873039 [TBL] [Abstract][Full Text] [Related]
7. Heparin-Induced Allosteric Changes in SARS-CoV-2 Spike Protein Facilitate ACE2 Binding and Viral Entry. Petitjean SJL; Eeckhout S; Delguste M; Zhang Q; Durlet K; Alsteens D Nano Lett; 2023 Dec; 23(24):11678-11684. PubMed ID: 38055954 [TBL] [Abstract][Full Text] [Related]
8. Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein. Tang X; Liu Y; Wang J; Long T; Yee Mok BW; Huang Y; Peng Z; Jia Q; Liu C; So PK; Pui-Kam Tse S; Hei Ng C; Liu S; Sun F; Tang S; Yao ZP; Chen H; Guo Y J Biol Chem; 2024 Jun; 300(6):107390. PubMed ID: 38777146 [TBL] [Abstract][Full Text] [Related]
9. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. Muralidar S; Gopal G; Visaga Ambi S J Med Virol; 2021 Sep; 93(9):5260-5276. PubMed ID: 33851732 [TBL] [Abstract][Full Text] [Related]
10. Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs. Niu S; Zhao Z; Liu Z; Rong X; Chai Y; Bai B; Han P; Shang G; Ren J; Wang Y; Zhao X; Liu K; Tian W-x; Wang Q; Gao GF J Virol; 2024 Mar; 98(3):e0115723. PubMed ID: 38305152 [TBL] [Abstract][Full Text] [Related]
11. Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles. Lim K; Nishide G; Yoshida T; Watanabe-Nakayama T; Kobayashi A; Hazawa M; Hanayama R; Ando T; Wong RW J Extracell Vesicles; 2021 Dec; 10(14):e12170. PubMed ID: 34874124 [TBL] [Abstract][Full Text] [Related]
12. Cooperative multivalent receptor binding promotes exposure of the SARS-CoV-2 fusion machinery core. Pak AJ; Yu A; Ke Z; Briggs JAG; Voth GA Nat Commun; 2022 Feb; 13(1):1002. PubMed ID: 35194049 [TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic domain and enzymatic activity of ACE2 are not required for PI4KB dependent endocytosis entry of SARS-CoV-2 into host cells. Yang H; Yuan H; Zhao X; Xun M; Guo S; Wang N; Liu B; Wang H Virol Sin; 2022 Jun; 37(3):380-389. PubMed ID: 35272059 [TBL] [Abstract][Full Text] [Related]
14. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
15. Discovery of a Potential Allosteric Site in the SARS-CoV-2 Spike Protein and Targeting Allosteric Inhibitor to Stabilize the RBD Down State using a Computational Approach. Li T; Yan Z; Zhou W; Liu Q; Liu J; Hua H Curr Comput Aided Drug Des; 2024; 20(6):784-797. PubMed ID: 37493168 [TBL] [Abstract][Full Text] [Related]
16. Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor. Kim YS; Chung HS; Noh SG; Lee B; Chung HY; Choi JG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445310 [TBL] [Abstract][Full Text] [Related]
17. Mechanical activation of spike fosters SARS-CoV-2 viral infection. Hu W; Zhang Y; Fei P; Zhang T; Yao D; Gao Y; Liu J; Chen H; Lu Q; Mudianto T; Zhang X; Xiao C; Ye Y; Sun Q; Zhang J; Xie Q; Wang PH; Wang J; Li Z; Lou J; Chen W Cell Res; 2021 Oct; 31(10):1047-1060. PubMed ID: 34465913 [TBL] [Abstract][Full Text] [Related]
18. Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains. Qing E; Kicmal T; Kumar B; Hawkins GM; Timm E; Perlman S; Gallagher T mBio; 2021 Aug; 12(4):e0159021. PubMed ID: 34340537 [TBL] [Abstract][Full Text] [Related]
19. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target. Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993 [TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 omicron RBD forms a weaker binding affinity to hACE2 compared to Delta RBD in Le HT; Tran LH; Phung HTT J Biomol Struct Dyn; 2024 May; 42(8):4087-4096. PubMed ID: 37345564 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]